docetaxel anhydrous has been researched along with glyceryl behenate in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (glyceryl behenate) | Trials (glyceryl behenate) | Recent Studies (post-2010) (glyceryl behenate) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 160 | 3 | 104 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbarzadeh, M; Bazzaz, R; Ghanbarzadeh, S; Ghorbani, M; Hajipour, H; Khiavy, HA; Kooti, W; Maroufi, NF; Mazrakhondi, SAM; Pirouzpanah, SM; Ramezani, F; Sabzichi, M; Vahedian, V | 1 |
| Andrade, BYG; Báo, SN; da Rocha, MCO; da Silva, PB; de Oliveira, JV; Estrela-Lopis, I; Longo, JPF; Merker, C; Radicchi, MA; Venus, T | 1 |
2 other study(ies) available for docetaxel anhydrous and glyceryl behenate
| Article | Year |
|---|---|
Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers; Drug Liberation; Fatty Acids; Flavonoids; G1 Phase Cell Cycle Checkpoints; Humans; Nanoparticles | 2020 |
Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Disease Models, Animal; Docetaxel; Drug Carriers; Fatty Acids; Female; Hexoses; Inhibitory Concentration 50; Lipids; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles; NIH 3T3 Cells; Particle Size; Poloxamer | 2020 |